Triple-Negative Phenotype of Poorly-differentiated Metaplastic Breast Carcinoma in a Male: An Oncological Rarity

被引:0
|
作者
Rehman, Abdul [1 ]
机构
[1] Pakistan Atom Energy Commiss PAEC Gen Hosp, Dept Gen Surg, Islamabad, Pakistan
关键词
Metaplastic carcinoma; Carcinosarcoma; Immunohistochemistry; Tumour markers; Triple-negative phenotype; CANCER;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Metaplastic breast carcinoma (MBC) is an extremely rare breast malignancy having highly aggressive clinicopathological behaviour and dismal prognosis. A 75 years old man presented with a painless lump on right side of his chest along with two additional lumps in the ipsilateral axillary and inguinal areas. Microscopic evaluation and immunohistochemistry of tru-cut tissue biopsies of the lumps and that of. mastectomy specimen revealed a triple-negative phenotype of poorly-differentiated metaplastic breast carcinoma with metastatic deposits to the axillary and inguinal lymph nodes. Exhaustive internet research has revealed only a few case reports of MBC in the men; thus highlighting its absolute oncological rarity.
引用
收藏
页码:370 / 372
页数:3
相关论文
共 50 条
  • [31] Prognosis of Metaplastic Breast Cancer: Poorer Than the Rest of Triple-Negative Breast Cancer
    Jung, S-Y
    Kim, H. Y.
    Min, S. Y.
    Lee, S. J.
    Park, C.
    Kwon, Y.
    Kim, E-A
    Ko, K. L.
    Lee, K. S.
    Park, I. H.
    Shin, K. H.
    Lee, S.
    Kim, S. W.
    Kang, H-S
    Ro, J.
    CANCER RESEARCH, 2009, 69 (24) : 725S - 726S
  • [32] Commentary: Outcomes of Metaplastic Breast Cancer vs. Triple-Negative Breast Cancer
    Gaurav Agarwal
    K. M. M. Vishvak Chanthar
    World Journal of Surgery, 2023, 47 : 3203 - 3204
  • [33] The Prognosis of Metaplastic Breast Cancer Patients Compare to Triple-Negative Breast Cancer Patients
    Cho, D. H.
    Jang, J. H.
    Lee, S. K.
    Choi, M-Y
    Koo, M. Y.
    Hur, S. M.
    Bae, S. Y.
    Kim, S. M.
    Choe, J-H
    Lee, J. E.
    Kim, J-H
    Kim, J. S.
    Nam, S. J.
    Yang, J-H
    CANCER RESEARCH, 2010, 70
  • [34] Cytologic features of triple-negative breast carcinoma
    Bonzanini, Mariella
    Morelli, Luca
    Bonandini, Elena Maria
    Leonardi, Elena
    Pertile, Riccardo
    Dalla Palma, Paolo
    CANCER CYTOPATHOLOGY, 2012, 120 (06) : 401 - 409
  • [35] Commentary: Outcomes of Metaplastic Breast Cancer vs. Triple-Negative Breast Cancer
    Agarwal, Gaurav
    Chanthar, K. M. M. Vishvak
    WORLD JOURNAL OF SURGERY, 2023, 47 (12) : 3203 - 3204
  • [36] Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
    Giuseppe Viale
    Nicole Rotmensz
    Patrick Maisonneuve
    Luca Bottiglieri
    Emilia Montagna
    Alberto Luini
    Paolo Veronesi
    Mattia Intra
    Rosalba Torrisi
    Anna Cardillo
    Elisabetta Campagnoli
    Aron Goldhirsch
    Marco Colleoni
    Breast Cancer Research and Treatment, 2009, 116 : 317 - 328
  • [37] Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity
    Viale, Giuseppe
    Rotmensz, Nicole
    Maisonneuve, Patrick
    Bottiglieri, Luca
    Montagna, Emilia
    Luini, Alberto
    Veronesi, Paolo
    Intra, Mattia
    Torrisi, Rosalba
    Cardillo, Anna
    Campagnoli, Elisabetta
    Goldhirsch, Aron
    Colleoni, Marco
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (02) : 317 - 328
  • [38] Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: Prognostic implications of EGFR immunoreactivity
    Colleoni, M.
    Rotmensz, N.
    Maissoneuve, P.
    Bottiglieri, L.
    Montagna, E.
    Torrisi, R.
    Cardillo, A.
    Goldhirsch, A.
    Viale, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype
    Murphy, D. C.
    Johnson, S. J.
    Aspinall, S.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2020, 102 (03) : E63 - E66
  • [40] Genomic and protein alterations in 126 triple-negative (TN) metaplastic breast cancers
    Millis, Sherri Z.
    Feldman, Rebecca A.
    O'Shaughnessy, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)